Swiss biotech firm grabs $147m Series B
The investors include EQT Life Sciences, Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus and UPMC Enterprises.
The investors include EQT Life Sciences, Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus and UPMC Enterprises.
Copyright PEI Media
Not for publication, email or dissemination